Zobrazeno 1 - 10
of 153
pro vyhledávání: '"Philip O. Livingston"'
Autor:
Wolfgang W. Scholz, Philip O. Livingston, Govind Ragupathi, Feng Hong, Xiaohong Wu, Shu-Man Sun, Ritsuko Sawada
Purpose: The carbohydrate antigen sialyl-Lewisa (sLea), also known as CA19.9, is widely expressed on epithelial tumors of the gastrointestinal tract and breast and on small-cell lung cancers. Since overexpression of sLea appears to be a key event in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70001bbc550e6ccd97b2b14809567927
https://doi.org/10.1158/1078-0432.c.6520268
https://doi.org/10.1158/1078-0432.c.6520268
Legend for supplementary figures - PDF file 62K, Supplementary Figure Legend
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b572befb2cf852e8b4587174ac0901f
https://doi.org/10.1158/1078-0432.22446662.v1
https://doi.org/10.1158/1078-0432.22446662.v1
Purpose: We addressed the possibility that low levels of tumor cell-bound antibodies targeting gangliosides might accelerate tumor growth.Experimental Design: To test this hypothesis, we treated mice with a range of monoclonal antibody (mAb) doses ag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f7deedbc0391508d07cd87076b4933a
https://doi.org/10.1158/1078-0432.c.6520820
https://doi.org/10.1158/1078-0432.c.6520820
Autor:
Wolfgang W. Scholz, Philip O. Livingston, Govind Ragupathi, Feng Hong, Xiaohong Wu, Shu-Man Sun, Ritsuko Sawada
Supplementary Figure S1; Supplementary Tables S1-S2.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e9d32b76213347c761f1d52ea13c2d1
https://doi.org/10.1158/1078-0432.22444706.v1
https://doi.org/10.1158/1078-0432.22444706.v1
Supplementary Figure B - PDF file 42K, CHLA136Luc or H524 cells treated with Human sera Complement (HuC') or heat inactivated HuC'(De-HuC') with or without the mAbs (3F8, PGNX and R24) for overnight. De- HuC' was achieved by heating the human complem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7445722510c0953499443171ca7be84f
https://doi.org/10.1158/1078-0432.22446668
https://doi.org/10.1158/1078-0432.22446668
Autor:
Evan Rosenbaum, Rashmi Chugh, Christopher W. Ryan, Mark Agulnik, Mohammed M. Milhem, Suzanne George, Robin L. Jones, Bartosz Chmielowski, Brian A. Van Tine, Hussein Tawbi, Anthony D. Elias, William L. Read, G. Thomas Budd, Li-Xuan Qin, Eve T. Rodler, Joe Hirman, Paul Weiden, Cathryn M. Bennett, Philip O. Livingston, Govind Ragupathi, David Hansen, Sandra P. D'Angelo, William D. Tap, Gary K. Schwartz, Robert G. Maki, Richard D. Carvajal
Publikováno v:
European journal of cancer (Oxford, England : 1990). 176
Recurrence after resection of metastatic sarcoma is common. The gangliosides GM2, GD2 and GD3 are strongly expressed across sarcoma subtypes. We hypothesised that generation of anti-ganglioside antibodies would control micrometastases and improve out
Autor:
Nerissa Viola-Villegas, Marija Drobjnak, Ritsuko Sawada, Govind Ragupathi, Kuntal K. Sevak, Michael J. Evans, Philip O. Livingston, Jason S. Lewis, Samuel L. Rice, Sean Carlin, Xiaohong Wu, Wolfgang W. Scholz
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, vol 54, iss 11
UnlabelledDespite their considerable advantages, many circulating biomarkers have well-documented limitations. One prominent shortcoming in oncology is a high frequency of false-positive indications for malignant disease in upfront diagnosis. Because
Publikováno v:
Clinical Cancer Research. 19:4728-4739
Purpose: We addressed the possibility that low levels of tumor cell-bound antibodies targeting gangliosides might accelerate tumor growth. Experimental Design: To test this hypothesis, we treated mice with a range of monoclonal antibody (mAb) doses a
Publikováno v:
Novel Immunologic Adjuvants. :54-66
Autor:
Lauren E. Abrey, Lee M. Krug, Govind Ragupathi, Harold J. Jennings, Ronglai Shen, Chandra Hood, Constantine George, Philip O. Livingston, Feng Hong, Mark G. Kris
Publikováno v:
Cancer Immunology, Immunotherapy. 61:9-18
Polysialic acid (polySA) is a polymer side chain bound to the neural cell adhesion molecule that is extensively expressed on the surface of small cell lung cancer (SCLC) cells. In our previous study, a robust antibody response was noted in patients w